Background-Pacemaker pocket infection is a potentially serious problem after permanent pacemaker implantation. Antibiotic prophylaxis is commonly prescribed to reduce the incidence of this complication, but current trial evidence of its efficacy is conflicting. A large prospective randomised trial was therefore performed of antibiotic prophylaxis in permanent pacemaker implantation. The intention was firstly to determine whether antibiotic prophylaxis is efficacious in these patients and secondly to identify which patients are at the highest risk of infection. Methods-A prospective randomised open trial of flucloxacillin (clindamycin if the patient was allergic to penicillin) v no antibiotic was performed in a cohort of patients undergoing first implantation of a permanent pacing system over a 17 month period. Intravenous antibiotics were started at the time of implantation and continued for 48 hours. The trial endpoint was a repeat operation for an infective complication. Results-473 patients were entered into a randomised trial. 224 received antibiotic prophylaxis and 249 received no antibiotics. A further 183 patients were not randomised but were treated according to the operator's preference (64 antibiotics, 119 no antibiotics); these patients are included only in the analysis of predictors ofinfection. Patients were followed up for a mean (SD) of 19(5) months. Among the patients in the randomised group there were nine infections requiring a repeat operation, all in the group not receiving antibiotic (P = 0.003). In the total patient cohort there were 13 infections, all but one in the non-antibiotic group (P = 0.006).
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Nine of the infections presented as erosion of the pulse generator or electrode, three as septicaemia secondary to Staphylococcus aureus, and one as a pocket abscess secondary to Staphylococcus epidermidis. Infections were significantly more common when the operator was inexperienced (< 100 previous patients), the operation was prolonged, or after a repeat operation for non-infective complications (principally lead displacement).
Infection was not significantly more common in patients identified preoperatively as being at high risk (for example patients with diabetes mellitus, patients receiving long term steroid treatment), although there was a trend in this direction. Conclusions-Antibiotic prophylaxis significantly reduced the incidence of infective complications requiring a repeat operation after permanent pacemaker implantation. It is suggested that antibiotics should be used routinely. (Br Heart J 1994; 72:339-343) Pacemaker pocket infection remains a potentially serious complication after permanent pacemaker implantation. Many operators routinely use antibiotic prophylaxis to reduce the incidence of this complication, but the trial evidence that this strategy is beneficial is not convincing. The two largest trials to date' 2 have conflicting conclusions. Muers et al' showed a small benefit of antibiotic prophylaxis in reducing pacemaker pocket and wound sepsis, whereas Ramsdale et al2 saw no such benefit.
With these conflicting studies in mind, we elected to perform a large prospective randomised trial of antibiotic prophylaxis. We hoped to establish firstly whether the incidence of serious infection, which we defined as infection requiring a repeat operation, was reduced. These serious infections have been reported to occur in up to 5% of implants.3 They are unambiguous as an endpoint and their prevention should be the main goal of antibiotic prophylaxis. The secondary purpose of the trial was to identify patients at high risk of infection in whom antibiotic prophylaxis may be most efficacious, if the trial did not produce a statistically significant result in favour of the use of antibiotic prophylaxis. Randomised Non-randomised patients were not routinely followed up in the cardiac clinic.
Methods

DEFINITION OF INFECTION
The endpoint of the trial was a repeat operation for an infective complication. All pacemaker complications with the potential to require a repeat operation were referred back to the Freeman Hospital for assessment and treatment. Patients with superficial wound infections which required only local treatment or antibiotics by mouth were not deemed to have an infective complication in the analysis of this study. A repeat operation was performed either for septicaemia, pocket abscess, or erosion of the pulse generator or electrode through the skin. In patients without systemic infection the pulse generator was, where technically feasible, cleaned with alcoholic betadine and resited at a single operation. In other patients the infected system was explanted with, if necessary, connection of the electrode to an external pulse generator. In these patients a new, contralateral pacing system was implanted at a later date. All repeat operations were performed under general anaesthesia with antibiotic cover guided, where available, by microbiological culture results. We have described the procedure and outcome for primary resiting of eroded pulse generators elsewhere.4 DATA ANALYSIS Student's t test, Fisher's exact test, and the x2 test with, where appropriate, Yates's correction were used for statistical analysis. Significance was assumed to be P < 0 05.
Results
PATIENT COHORT
The figure shows a breakdown of the patient cohort. A total of 715 patients was screened for inclusion in the trial. One hundred and thirty nine (19-4%) of these had temporary pacing electrodes in situ; 576 (80 6%) did not. In the group without temporary electrodes, 33 Table 1 shows the baseline characteristics of the patient cohort, including randomised and non-randomised patients. There was no significant difference in baseline characteristics between randomised and non-randomised patients. There was no significant difference between the antibiotic and non-antibiotic groups of patients with respect to age, sex, pacing mode, procedure time, or perioperative blood loss (calculated from the weight of blood saturated swabs). A similar proportion of pacemakers in each group was implanted by junior operators with 100 cases or less previous pacing experience. There was no difference in the proportion of patients in each group who had one or more preexisting disorders likely to predispose to infection-for example, diabetes, corticosteroid treatment, malignancy, or a recent operation.
Twenty eight patients (4-3%) had a repeat operation for non-infective complications. This rate was similar in the treated and untreated groups (table 1) . Twenty patients (3 0%) had one or both electrodes repositioned less than 14 days after the initial operation and six patients (0 9%) had electrodes repositioned or replaced 14 days to six months after implantation. Two patients (03%) required early pulse generator changes because of generator failure (six days and 49 days after implantation). All patients who received antibiotic prophylaxis at implanta- tion had antibiotics either continued or prescribed again at the time of the repeat operation. Four patients who did not receive prophylaxis at implantation received antibiotics at the time of the repeat operation. In each of these early repositioning of a displaced electrode was carried out. Table 2 shows observed infection rates for antibiotic and non-antibiotic groups. Among the randomised patients there was a total of nine infections requiring a repeat operation, two of which occurred in patients with temporary electrodes. All infections were in the nonantibiotic group and this represents a statistically significant benefit for antibiotic prophylaxis (P = 0 003). In the total patient cohort, including nonrandomised patients, there were 13 infections, all but one in the non-antibiotic group. This difference was also statistically significant. Nine of these infections occurred in patients without temporary electrodes, all in the nonantibiotic group, and this difference was also statistically significant. Among patients with temporary electrodes antibiotic prophylaxis did not confer a benefit. There were four infections in this group, which represents an overall infection rate of 3-5%. One of the patients had received antibiotics and the difference between the antibiotic and nonantibiotic groups was not statistically significant. Table. 3 gives details of the patients who became clinically infected. The most common mode of presentation of pacemaker infection was erosion of either the pulse generator or the pacing electrode. This occurred in nine patients 171 (77) days after implantation (range 97-346 days). Bacterial pathogens were identified in two patients (Staphyloccus aureus and Enterococcus faecalis), skin or mixed faecal flora in five patients, and there was no bacterial growth in two patients.
PACEMAKER INFECTIONS
MODES OF PRESENTATION OF INFECTED PACEMAKERS
Three patients presented with septicaemia. In each instance the patient presented within 10 days of the operation and the organism responsible was Staphylococcus aureus. One patient presented with a closed pocket abscess. This patient also presented early and the organism was Staphylococcus epidermidis. None of the patients died as a result of pacemaker infection. Table 4 gives the factors which were of significance in the prediction of pacemaker infection. A significant excess of pacemakers which became infected were implanted by inexperienced operators who had previously performed less than 100 pacemaker implantations. Conversely, no infection occurred in patients where the operator had previously performed more than 500 operations. The mean operation time was significantly prolonged in patients who developed infections. Those patients who had a repeat operation for non-infective complications had a significantly higher infection rate. Infection was not significantly more common in patients identified preoperatively as being at high risk of infection, though there was a trend in this direction. There was no difference between infected and non-infected groups for age, sex, or perioperative blood loss. Dual chamber pacemakers were no more likely to become infected than single chamber pacemakers.
PREDICTORS OF PACEMAKER INFECTION
Discussion
In this large prospective randomised trial we have shown a highly significant benefit for antibiotic prophylaxis in preventing those Firstly, the patients of Ramsdale et al 2 stayed in hospital longer (three days compared with one day) and were followed up more often than ours (four times in the first year compared with two). It is possible that careful surveillance and antibiotic treatment of wound infections may have resulted in the secondary prevention of serious infection in that trial. We have no data on the incidence of superficial wound infection or of antibiotics prescribed out of hospital, and so cannot speculate whether any serious infections were aborted by early antibiotic treatment in our patient cohort.
Secondly, there was a high incidence of late pulse generator erosion in our series (9/13 infections were erosions), whereas Ramsdale et al2 observed none. This striking difference may have been caused by the use of a topical antibiotic spray into the generator pocket in all patients by Ramsdale et al. 2 We prospectively defined erosions as infections for the purposes of this trial because they were a cause for a late repeat operation, possibly of infective origin.7 In the event, only seven of nine erosions were overtly infected; the remaining two were microbiologically sterile. It has been argued that sterile erosions may be the result of mechanical factors alone rather than an infective process. In support of this we have previously shown that pulse generator repeat implantation is most often successful when erosions are sterile.4 That two sterile erosions occurred in the non-antibiotic group in this trial may be random chance or it may be that all erosions require an underlying infective process to initiate them. Interestingly, to date there have been no erosions in the antibiotic group in our series.
Inexperience of the operators may have contributed to the infection rate in our series. We prospectively defined a learning curve of 100 cases and, by this definition, approximately one third of pacemakers were implanted by inexperienced operators. A significant excess of infections occurred in this group of patients. In Ramsdale et al's study2 two out of five operators were in training (the number of cases previous experience was not specified); Muers et al' do not report the proportion of operators in training, though it is probable that some of the operators in their series were, by our definition, in training.
In our series, the duration of the operation and repeat operation for non-infective complications were significantly associated with infection. None of the previous prospective trials specifically addressed either of these factors, though it seems logical that the time the wound was open and reopening the wound predispose to infection. Morgan et a18 noted that a repeat operation predisposed to septicaemia in patients with permanent pacemakers. There was a trend towards a higher infection rate in patients identified preoperatively as being at high risk of infection. This did not reach statistical significance, which is in accord with the data of Muers et al.I
Antibiotic prophylaxis was not beneficial in the subgroup of patients with temporary pacing electrodes in situ. This subgroup analysis was prospectively defined and, given the known high rate of infection of temporary electrodes,9 the absence of benefit is surprising. A relatively small number of patients with temporary electrodes were randomised and exclusions for overt sepsis were common in this series. For these reasons we are not confident that antibiotic prophylaxis is not beneficial in these patients and we would advocate its use on the basis of the highly significant result for the whole cohort. A large trial focused on patients with temporary electrodes would be of interest.
In conclusion, antibiotic prophylaxis significantly reduces the incidence of serious infective complications requiring a repeat operation after permament pacemaker implantation. Permanent pacemaker infections occur most commonly when the operation time is prolonged, the operator is inexperienced, and after a repeat operation for electrode displacement. We suggest that antibiotic prophylaxis (guided by the sensitivity of local bacterial flora) is used routinely in permanent pacemaker implantation.
